Dr. Gary Karlin Michelson, Found Animals Foundation, Forbes billionaire, 20 Million Minds, Alya

Dr. Gary Karlin Michelson, Found Animals Foundation, Forbes billionaire, 20 Million Minds, Alya
Dr. Gary Karlin Michelson, Found Animals Foundation, Forbes billionaire, 20 Million Minds, Alya

Wednesday, October 22, 2014

The evolution of the elusive Dr Gary Michelson Prize - moving the goal posts - Replacement post

The "evolution" of the elusive Dr. Gary Michelson Prize - moving the goal posts

This entire Dr. Gary Michelson prize truly shows Gary's true nature. Without doing any research, thinking, talking to people such as his lawyers he announces his Prize. Prizes, contests are actually under control of the Attorney General. Gary didn't follow any of the legal guidelines. Besides that he keeps changing the prize to make it more difficult so he doesn't have to actually award the prize to anyone. 

Here is a summary with more detailed copy/paste from the actual Prize offering beneath that. 

2008 - Michelson Prize Details

Found Animals will offer a $25 million prize to the first entity to provide to the Foundation with a safe, effective, and practical non-surgical sterilant for use in cats and dogs. 

(I did that)

2009 - Michelson Prize Details

The winning entry for the Michelson Prize in Reproductive Biology will have, at minimum, the following characteristics:
Single dose, non-surgical sterilant

Safe and effective in male and female, cats and dogs
Suitable for administration in a field setting
Viable pathway to regulatory approval
Reasonable manufacturing process and cost
Found Animals may at its sole discretion, consider awarding a partial prize in the event that a product or technology not currently available has the potential to substantially eradicate pet overpopulation but cannot meet all of the above criteria.

(I did that).

2010 - Michelson Prize Details

The winning entry for the Michelson Prize in Reproductive Biology will have, at minimum, the following characteristics:
Single dose, non-surgical sterilant
Safe and effective in male and female, cats and dogs
Suitable for administration in a field setting
Viable pathway to regulatory approval
Reasonable manufacturing process and cost  (I did that)
Found Animals expects exclusive commercialization rights to the prize winning product. The Foundation intends to pursue further development and commercialization activities as needed to bring the winning product or technology to market for use in cats and dogs.
Final decisions regarding the Prize award will be at the sole discretion of the Foundation.  

(These are new requirements. In essence he doesn't have to award the prize to anyone. He also wants full commercialization rights)

2011 - Michelson Prize Criteria

The winning entry for the Michelson Prize in Reproductive Biology will have, at minimum, the following characteristics, as defined below:
Single dose, non-surgical sterilant
Administered in a single patient encounter
Must not require general anesthesia
May require sedation or local anesthesia
Subcutaneous implant is considered nonsurgical for the purpose of the Michelson Prize
Must induce permanent sterility for the reproductive lifetime of the species, defined as
at least 10 years after administration
Will generally require 3 years of data with a trend line with no expectation of recovery,
may require that study extends for additional time
Eliminating heat cycle in females highly preferred
Safe and effective in male and female, cats and dogs
Must be one product for both species and genders
Must be no more dangerous than surgical gonadectomy
Must be safe for treated animal, environment (including predators), and person
administering the product
Efficacy must be ≥ spay/neuter. For the purposes of experimental design, a lower
standard of proof may be acceptable
Must not induce clinical abnormalities or pathological lesions at 1X dose in safety
studies
Must not be carcinogenic, mutagenic, or clastogenic
Must not be a “bait” formulation (i.e. administered without handling of treated animals)
Suitable for administration in a field setting
May require refrigeration/cold chain but no frozen storage, water source, or other
electricity than refrigeration
Must have shelf life of at least two years
Must not require sterile environment/ surgical theater
Viable pathway to regulatory approval
As defined by FDA/CVM as a prescription product in dogs & cats
Regulatory approval will be sought by Found Animals
Reasonable manufacturing process and cost
Target is a low cost product to deliver to shelters
Must be no greater than $50 cost per dose to deliver labeled, packaged product to the
Foundation or other distributor, with <$25/dose preferred when manufactured at
commercial scale 

(This is obviously a completely different prize now. He keeps changing the rules so no one can win. Let me add one more requirement while I'm here)

All animals who are administered this sterilant must defecate gold bricks ( ≥18K) and urinate liquid platinum...while reciting winning lotto numbers...while telling Gary Michelson that his biceps look great.

Dr. Gary Michelson is guilty of moving the goal posts. No one has won the $25,000,000 prize and they never will at this rate. Instead Gary's taken everyone's ideas and is doing research in house. Maybe he will claim the prize for himself.

________________________________________
Actual copy/paste from saved previous versions of the website. 

Here is the Dr. Gary Michelson prize from 2008


"The Michelson Prize and Grants in Reproductive Biology
Found Animals is proud to announce the Michelson Prize and Grants in Reproductive Biology.

The Michelson Prize in Reproductive Biology: 
$25 million for innovation in non-surgical sterilization for cats and dogs

Found Animals will offer a $25 million prize to the first entity to provide to the Foundation with a safe, effective, and practical non-surgical sterilant for use in cats and dogs.

The Michelson Grants in Reproductive Biology: 
Up to $50 million of grant funding available for research directed to achieving this goal

Found Animals will provide up to $50 million in grant funding for promising research in pursuit of a safe, effective, and practical non-surgical sterilant for use in cats and dogs."

Here is the Dr. Gary Michelson prize from 2009


"Michelson Prize Details
More details about the Michelson Prize in Reproductive Biology will be available in the coming months.  Please join the mailing list to receive the latest news and updates.

The winning entry for the Michelson Prize in Reproductive Biology will have, at minimum, the following characteristics:
Single dose, non-surgical sterilant
Safe and effective in male and female, cats and dogs
Suitable for administration in a field setting
Viable pathway to regulatory approval
Reasonable manufacturing process and cost
Found Animals may at its sole discretion, consider awarding a partial prize in the event that a product or technology not currently available has the potential to substantially eradicate pet overpopulation but cannot meet all of the above criteria.

Process
All Prize claims will be reviewed by Found Animals and their Scientific Advisors.  Claimants will be required to submit a data package demonstrating satisfactory achievement of the Prize criteria.  Found Animals may ask for clarification or request additional data in order to verify a Prize claim. 

Found Animals anticipates the first opportunity for Prize claim review will occur in mid-2009.  If you have a product or technology that you believe meets all of the Michelson Prize in Reproductive Biology criteria, please contact Found Animals at: michelsonprize@foundanimals.org . 

Final decisions regarding the Prize award will be at the sole discretion of the Foundation.  

Guidelines
All animal research performed in pursuit of the Michelson Prize in Reproductive Biology must conform to Found Animals' standards for humane treatment of animal subjects.  Click here to view or download the Animal Welfare Guidelines.  

In order to claim the Michelson Prize in Reproductive Biology, the claiming entity must agree to all Prize Terms and Conditions and certify that all Prize guidelines were followed.  Detailed Prize Terms and Conditions will be available by mid-2009.

Found Animals expects exclusive commercialization rights to the Prize winning product. The Foundation intends to pursue further development and commercialization activities as needed to bring the winning product or technology to market for use in cats and dogs.

The Michelson Prize in Reproductive Biology is an international competition open to any entity from any country.
© 2009 Found Animals Foundation, Inc.

Here is the Dr. Gary Michelson prize from 2010

Michelson Prize Details
The winning entry for the Michelson Prize in Reproductive Biology will have, at minimum, the following characteristics:
Single dose, non-surgical sterilant
Safe and effective in male and female, cats and dogs
Suitable for administration in a field setting
Viable pathway to regulatory approval
Reasonable manufacturing process and cost

Process
All prize claims will be reviewed by Found Animals and their scientific advisors.  Claimants will be required to submit a data package demonstrating satisfactory achievement of the prize criteria.  Found Animals may ask for clarification or request additional data in order to verify a prize claim. 

If you have a product or technology you believe meets all of the Michelson Prize in Reproductive Biology criteria, please contact Found Animals at: michelsonprize@foundanimals.org . 

Final decisions regarding the prize award will be at the sole discretion of the Foundation.  

Guidelines
All animal research performed in pursuit of the Michelson Prize in Reproductive Biology must conform to Found Animals' standards for humane treatment of animal subjects.  Click here to view or download the Animal Welfare Guidelines.  

In order to claim the Michelson Prize in Reproductive Biology, the claiming entity must agree to all prize terms and conditions and certify that all prize guidelines were followed.

Found Animals expects exclusive commercialization rights to the prize winning product. The Foundation intends to pursue further development and commercialization activities as needed to bring the winning product or technology to market for use in cats and dogs.

The Michelson Prize in Reproductive Biology is an international competition open to any entity from any country.

Please join the mailing list to receive the latest news and updates.
© 2010 Found Animals Foundation, Inc.

Here is the Dr. Gary Michelson prize from 2011

Michelson Prize Criteria
The winning entry for the Michelson Prize in Reproductive Biology will have, at minimum, the following characteristics, as defined below:
Single dose, non-surgical sterilant
Administered in a single patient encounter
Must not require general anesthesia
May require sedation or local anesthesia
Subcutaneous implant is considered nonsurgical for the purpose of the Michelson Prize
Must induce permanent sterility for the reproductive lifetime of the species, defined as
at least 10 years after administration
Will generally require 3 years of data with a trend line with no expectation of recovery,
may require that study extends for additional time
Eliminating heat cycle in females highly preferred
Safe and effective in male and female, cats and dogs
Must be one product for both species and genders
Must be no more dangerous than surgical gonadectomy
Must be safe for treated animal, environment (including predators), and person
administering the product
Efficacy must be ≥ spay/neuter. For the purposes of experimental design, a lower
standard of proof may be acceptable
Must not induce clinical abnormalities or pathological lesions at 1X dose in safety
studies
Must not be carcinogenic, mutagenic, or clastogenic
Must not be a “bait” formulation (i.e. administered without handling of treated animals)
Suitable for administration in a field setting
May require refrigeration/cold chain but no frozen storage, water source, or other
electricity than refrigeration
Must have shelf life of at least two years
Must not require sterile environment/ surgical theater
Viable pathway to regulatory approval
As defined by FDA/CVM as a prescription product in dogs & cats
Regulatory approval will be sought by Found Animals
Reasonable manufacturing process and cost
Target is a low cost product to deliver to shelters
Must be no greater than $50 cost per dose to deliver labeled, packaged product to the
Foundation or other distributor, with <$25/dose preferred when manufactured at
commercial scale

And here is the Dr. Gary Michelson prize from today, 2013

http://michelson.foundanimals.org/michelson-prize/michelson-prize-criteria

Mary Cummins of Animal Advocates is a wildlife rehabilitator licensed by the California Department of Fish and Game and the USDA. Mary Cummins is also a licensed real estate appraiser in Los Angeles, California.




Dr Gary Michelson, Michelson Prize, $75 million, Found Animals Foundation, Dr. Gary Michelson, Gary Michelson, Gary, Michelson, Gerald, Michaelson, Gary Michaelson, G Karlin Michelson, Mary Cummins, Animal Advocates, marycummins.com, animaladvocates.us, Gary Karlin Michelson, Gary K Michelson, Karlin Michelson, Alya Michelson, Aimee Gilbreath, teak, farm, billionaire, Forbes, lawsuit, worth, married, fraud, pitbull, purebred, bribe, bribery, patent, spine, animal nut, patent troll, thief, criminal, childhood, philadelphia, pennsylvania, boca de canon, Los Angeles, California, Ed Boks, Edward Boks, Antonio Villaraigosa, steve cooley, jackie lacey, campaign, donation, district attorney, inventor, hall of fame, grandmother, hand, fire, burn, 20, million minds, text book, free, surgery, surgical, twenty million minds, dog, high school, law, lawyer, doctor, dr., Michelson Medical Research Foundation, foundation, wilshire, Karlin Asset Management, KAM, Found Animals Legislative Fund, mom, dad, mother, father, brother, Gracie, bull, spay, neuter, adopt, buy, capital, karlin ventures, david cohen, tianxiang zhuo, spinal, surgeon, ceo, Karlin Real Estate, charity, 501 3c, irs, nonprofit, non-profit, Gary Karlin Michelson M D Charitable Foundation, gay, homosexual, wayne pacelle, hsus, animal services, temple university, medical, school, born, flake, crazy, central high school, Hahnemann Medical College, drexel, jewish, russian, Medtronic, Wikipedia, grant, $25, $50, Kremlin, mail order bride, Karlin Holdings Limited Partnership, C & M Investment Group Limited, michelson technology at work, Infuse class action lawsuit, Karlin Opportunity Fund, Karlin OP, Medical Research Foundation Trust, Alya Michelson, Alya Gold, Alevtina Gold Michelson, Tina Gold, Alevtina Shchepetina, Alexander Shchepetina, Алевтина Щепетина, александр щепетин, sasha, ria novosti, USC, Japanica, Russian mail order bride, T'n'G, test tube girl, smile, orel, russia, moscow, journalist, pathological liar, #deanflorez #foundanimalsorg #alyamichelson #20MillionMinds #drGaryMichelson #GaryMichelson #20MM #JAPANICA #Forbes #billionaire #infuse #lawsuit #classaction
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)